Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis

被引:12
作者
Moroni, Gabriella [1 ,2 ]
Porata, Giulia [3 ]
Raffiotta, Francesca [4 ]
Frontini, Giulia [5 ]
Calatroni, Marta [1 ,2 ]
Reggiani, Francesco [1 ,2 ]
Banfi, Giovanni [6 ]
Ponticelli, Claudio [7 ]
机构
[1] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[2] IRCCS Humanitas Res Hosp, Nephrol & Dialysis Div, Rozzano, Italy
[3] ASST Santi Paolo & Carlo, UO Nefrol & Dialisi, Milan, Italy
[4] ASST Fatebenefratelli Sacco, UO Nefrol & Dialisi, Milan, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nefrol Dialisi & Trapianto Rene, Milan, Italy
[6] St Agostino Med Ctr, Milan, Italy
[7] Nephrol, Milan, Italy
来源
LUPUS SCIENCE & MEDICINE | 2022年 / 9卷 / 01期
关键词
RENAL OUTCOMES; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; CLASSIFICATION; AZATHIOPRINE; INFLAMMATION; TRIAL;
D O I
10.1136/lupus-2022-000721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Based on available data, the histological predictors of long-term outcome of lupus nephritis (LN) are not clearly defined. Aims of this retrospective study were: (i) to evaluate the change of chronicity index from the first to second kidney biopsy and to find the predictors of chronicity index increase and (ii) to detect the clinical/ histological features at first and at second kidney biopsy associated with long-term kidney function impairment. Methods Among 203 biopsy proven LN subjects, 61 repeated kidney biopsy 49 months after the first biopsy. The reasons for repeated biopsy were: nephritic flares in 25 (41%), proteinuric flares in 21 (36%) of patients and protocol biopsy in 14 (23%) of cases. Results During 23-year follow-up, 25 patients presented a decrease in glomerular filtration rate (eGFR) >= 30%. At repeat biopsy, chronicity index increased in 44 participants (72%) and did not increase in 17 (28%). Nephritic syndrome and serum creatinine >1.6 mg/dL at presentation correlated with chronicity index increase (p=0.031, 0.027, respectively), cyclophosphamide therapy tended to protect against chronicity index increase (p=0.059). Kidney flares occurred in 53.6% of patients with vs 23.5% of those without chronicity index increase (p=0.035). Chronicity index increases of 3.5 points in patients with kidney flares vs 2 in those without flares (p=0.001). At second, but not at first kidney biopsy, two different models predicted eGFR decrease at multivariate analysis. The first included activity index >3 (OR: 3.230; p=0.013) and chronicity index >4 (OR: 2.905; p=0.010), and the second model included moderate/severe cellular/fibrocellular crescents (OR: 4.207; p=0.010) and interstitial fibrosis (OR: 2.525; p=0.025). Conclusion At second biopsy, chronicity index increased in 3/4 of participants. Its increase was predicted by kidney dysfunction at presentation and occurrence of LN flares. Kidney function impairment was predicted by both activity and chronicity index and by some of their components at repeated biopsy, but not at first biopsy.
引用
收藏
页数:10
相关论文
共 37 条
[1]   Interstitial inflammation and long-term renal outcomes in lupus nephritis [J].
Alsuwaida, A. O. .
LUPUS, 2013, 22 (14) :1446-1454
[2]   Strategy for second kidney biopsy in patients with lupus nephritis [J].
Alsuwaida, Abdulkareem ;
Husain, Sufia ;
Alghonaim, Mohammed ;
AlOudah, Noura ;
Alwakeel, Jamal ;
Ullah, Anhar ;
Kfoury, Hala .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) :1472-1478
[3]   PREDICTING RENAL OUTCOMES IN SEVERE LUPUS NEPHRITIS - CONTRIBUTIONS OF CLINICAL AND HISTOLOGIC DATA [J].
AUSTIN, HA ;
BOUMPAS, DT ;
VAUGHAN, EM ;
BALOW, JE .
KIDNEY INTERNATIONAL, 1994, 45 (02) :544-550
[4]  
AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75
[5]   PROGNOSTIC FACTORS IN LUPUS NEPHRITIS - CONTRIBUTION OF RENAL HISTOLOGIC DATA [J].
AUSTIN, HA ;
MUENZ, LR ;
JOYCE, KM ;
ANTONOVYCH, TA ;
KULLICK, ME ;
KLIPPEL, JH ;
DECKER, JL ;
BALOW, JE .
AMERICAN JOURNAL OF MEDICINE, 1983, 75 (03) :382-391
[6]   Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices [J].
Bajema, Ingeborg M. ;
Wilhelmus, Suzanne ;
Alpers, Charles E. ;
Bruijn, Jan A. ;
Colvin, Robert B. ;
Cook, H. Terence ;
D'Agati, Vivette D. ;
Ferrario, Franco ;
Haas, Mark ;
Jennette, J. Charles ;
Joh, Kensuke ;
Nast, Cynthia C. ;
Noel, Laure-Helene ;
Rijnink, Emilie C. ;
Roberts, Ian S. D. ;
Seshan, Surya V. ;
Sethi, Sanjeev ;
Fogo, Agnes B. .
KIDNEY INTERNATIONAL, 2018, 93 (04) :789-796
[7]   CONTROLLED TRIAL OF PULSE METHYLPREDNISOLONE VERSUS 2 REGIMENS OF PULSE CYCLOPHOSPHAMIDE IN SEVERE LUPUS NEPHRITIS [J].
BOUMPAS, DT ;
AUSTIN, HA ;
VAUGHN, EM ;
KLIPPEL, JH ;
STEINBERG, AD ;
YARBORO, CH ;
BALOW, JE .
LANCET, 1992, 340 (8822) :741-745
[8]   CONTROLLED-STUDIES OF ORAL IMMUNOSUPPRESSIVE DRUGS IN LUPUS NEPHRITIS - A LONG-TERM FOLLOW-UP [J].
CARETTE, S ;
KLIPPEL, JH ;
DECKER, JL ;
AUSTIN, HA ;
PLOTZ, PH ;
STEINBERG, AD ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (01) :1-8
[9]   Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine [J].
Chan, TM ;
Tse, KC ;
Tang, CSO ;
Lai, K ;
Li, FK .
LUPUS, 2005, 14 (04) :265-272
[10]   Factors associated with poor outcomes in patients with lupus nephritis [J].
Contreras, G ;
Pardo, V ;
Cely, C ;
Borja, E ;
Hurtado, A ;
De La Cuesta, C ;
Iqbal, K ;
Lenz, O ;
Asif, A ;
Nahar, N ;
Leclerq, B ;
Leon, C ;
Schulman, I ;
Ramirez-Seijas, F ;
Paredes, A ;
Cepero, A ;
Khan, T ;
Pachon, F ;
Tozman, E ;
Barreto, G ;
Hoffman, D ;
Suarez, MA ;
Busse, JC ;
Esquenazi, M ;
Esquenazi, A ;
Mayol, LG ;
Estrada, HG .
LUPUS, 2005, 14 (11) :890-895